HealthQuill Tumor
BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.
Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

Read More
A device, which uses a unique metabolic signature of cancer, differentiates tumour cells from normal blood cells without biopsy, according to Australian researchers. 
Drugs Health Pharma

Australian boffins make device to detect cancer from bloodstream

A device, which uses a unique metabolic signature of cancer, differentiates tumor cells from normal blood cells without biopsy, according to Australian researchers. 

Read More